Only patients with severe intracranial arterial stenosis may benefit from prophylactic stenting, according to a study from China in the February issue of Neurology.
Only patients with severe intracranial arterial stenosis may benefit from prophylactic stenting, according to a study from China in the February issue of Neurology.
Evidence has been lacking to demonstrate that patients with symptomatic severe intracranial arterial stenosis faced a higher stroke risk after angioplasty and stenting than patients with moderate blockage disease. The latest study proved that patients in the former group actually benefit from preventive stenting, said Dr. Wei-Jian Jiang, an interventional neuroradiologist at the Capital University of Medical Sciences' Tiantan Hospital in Beijing.
The data also suggest, however, that patients in the latter group may not benefit at all, according to Jiang.
Jiang and colleagues assessed 213 patients, aged 20 to 79, who underwent prophylactic primary stenting of symptomatic intracranial atherosclerotic stenosis between September 2001 and June 2005. Of these, 121 patients had a stenosis degree above 70%. All others had a moderate to low artery blockage below 69%. The investigators found that neither group showed a significant difference in terms of their respective risk of having a stroke after stenting.
The study's primary endpoints included lesion-related ischemic stroke, symptomatic brain hemorrhage, or subarachnoid hemorrhage after stenting. Ten endpoint events affected the severe stenosis group, with six occurring within 30 days of stenting and four during the follow-up period. Seven endpoint events affected the moderate group, four of which occurred within 30 days of stenting.
There was no significant difference in cumulative probability of primary endpoints between the severe (7.2% at one year and 8.2% at two years) stenosis group and the moderate (5.3% at one year and 8.3% at two years) group. No single factor was found to be associated with primary endpoints in the moderate stenosis group. Multivariable analysis revealed that stent failure was the only predictor of primary endpoints in the severe stenosis group.
Further research should establish the full benefit of stenting in patients with severe artery blockage before it can be used as a routine procedure, Jiang said. China's Ministry of Health supported the study.
For more information from the Diagnostic Imaging archives:
ISET meeting promises innovation, education - and football
Vessel analysis programs fall short in carotid measurement
Carotid stenting offers safe option in the elderly
The window expands for more effective stroke treatment
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.